DevCo’s Annual and Sustainability Review is Now Published

DevCo’s Annual and Sustainability Review is Now Published‍

The year 2025 marked another important step forward in DevCo’s journey. In a market environment characterized by continued uncertainty and geopolitical tensions, we remained focused on what matters most: supporting the long-term development of our companies. In 2025, all DevCo companies – Vexve, Medix Biochemica and Bluefors – delivered solid financial results, with total revenue reaching €600m. In late 2025, we completed our fourth platform investment, with further details to be announced.

A major milestone of the year was the successful closing of a capital raise of over €500 million for Vexve, a company we have owned since 2016. During the year, our own operations also continued to grow, with the team expanding to 20 experienced professionals and our investor base becoming broader and increasingly international. With this strong foundation, DevCo is well positioned to continue building global niche leaders in a sustainable, long-term manner.

Read and download the report here: DevCo Annual & Sustainability Review 2025

DevCo in brief
‍DevCo Partners is a long-term oriented active owner dedicated to building world-leading companies in selected niche markets. DevCo provides its companies with hands-on operational resources, strategic support and significant financial resources to support step changes in their performance. DevCo is currently a significant owner of three global niche leaders – Vexve, Medix Biochemica, and Bluefors.

‍